[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ES547578A0 - Un metodo de produccion de una solucion inyectable de un antraciclina glicosido - Google Patents

Un metodo de produccion de una solucion inyectable de un antraciclina glicosido

Info

Publication number
ES547578A0
ES547578A0 ES547578A ES547578A ES547578A0 ES 547578 A0 ES547578 A0 ES 547578A0 ES 547578 A ES547578 A ES 547578A ES 547578 A ES547578 A ES 547578A ES 547578 A0 ES547578 A0 ES 547578A0
Authority
ES
Spain
Prior art keywords
anthracicline
glycoside
production method
injectable solution
injectable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES547578A
Other languages
English (en)
Other versions
ES8605374A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Italia SRL
Original Assignee
Farmitalia Carlo Erba SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farmitalia Carlo Erba SRL filed Critical Farmitalia Carlo Erba SRL
Publication of ES547578A0 publication Critical patent/ES547578A0/es
Publication of ES8605374A1 publication Critical patent/ES8605374A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ES547578A 1984-10-22 1985-10-03 Un metodo de produccion de una solucion inyectable de un antraciclina glicosido Expired ES8605374A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB848426672A GB8426672D0 (en) 1984-10-22 1984-10-22 Pharmaceutical compositions

Publications (2)

Publication Number Publication Date
ES547578A0 true ES547578A0 (es) 1986-03-16
ES8605374A1 ES8605374A1 (es) 1986-03-16

Family

ID=10568553

Family Applications (1)

Application Number Title Priority Date Filing Date
ES547578A Expired ES8605374A1 (es) 1984-10-22 1985-10-03 Un metodo de produccion de una solucion inyectable de un antraciclina glicosido

Country Status (35)

Country Link
US (4) US4675311A (es)
JP (1) JPH0611700B2 (es)
KR (1) KR920005813B1 (es)
CN (1) CN85107562B (es)
AT (1) AT401345B (es)
AU (1) AU572003B2 (es)
BE (1) BE903484A (es)
BG (1) BG60934B2 (es)
CA (1) CA1248453A (es)
CH (1) CH667594A5 (es)
CS (1) CS270421B2 (es)
DE (1) DE3536896C2 (es)
DK (1) DK165620C (es)
ES (1) ES8605374A1 (es)
FI (2) FI853913A (es)
FR (1) FR2571966B1 (es)
GB (2) GB8426672D0 (es)
GR (1) GR852549B (es)
HK (1) HK94390A (es)
HU (1) HU197988B (es)
IE (1) IE56992B1 (es)
IL (1) IL76732A (es)
IT (1) IT1186779B (es)
MY (1) MY103956A (es)
NL (1) NL191308C (es)
NO (1) NO170616C (es)
NZ (1) NZ213885A (es)
PH (1) PH23982A (es)
PT (1) PT81347B (es)
RU (2) RU1836088C (es)
SE (1) SE467520B (es)
SG (1) SG80290G (es)
UA (2) UA19169A (es)
YU (1) YU46160B (es)
ZA (1) ZA858033B (es)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5124318A (en) * 1985-08-02 1992-06-23 Farmitalia Carlo Erba S.R.L. Injectable ready-to-use solutions containing an antitumor anthracycline glycoside
US5124317A (en) * 1985-08-02 1992-06-23 Farmitalia Carlo Erba S.P.A. Injectable ready-to-use solutions containing an antitumor anthracycline glycoside
US5977082A (en) 1985-08-02 1999-11-02 Pharmacia & Upjohn Company Injectable ready-to-use solutions containing an antitumor anthracycline glycoside
ES2198424T3 (es) * 1986-12-05 2004-02-01 Pharmacia Italia S.P.A. Soluciones inyectables listas para el empleo que contienen doxorrubicina.
JP2603480B2 (ja) * 1987-08-05 1997-04-23 住友製薬株式会社 安定化されたアンスラサイクリン系製剤
DE3801178A1 (de) * 1988-01-18 1989-07-27 Hoechst Ag Stabilisierte trockenzubereitung zytostatisch wirksamer anthracyclin-antibiotika und verfahren zu ihrer herstellung
US6300362B1 (en) 1990-07-25 2001-10-09 Novartis Ag (Formerly Sandoz Ltd.) Stabilized pharmaceutical compositions comprising acid donors
ATE357214T1 (de) 1996-12-30 2007-04-15 Battelle Memorial Institute Verwendung eines unverkapselten anti-krebs- wirkstoffs zur herstellung einer zubereitung zur behandlung von neoplasmen durch inhalation
US5942508A (en) * 1997-02-04 1999-08-24 Senju Pharmaceutical Co., Ltd. Method for solubilizing pyridonecarboxylic acid solubilizer thereof and aqueous solution containing solubilized pyridonecarboxylic acid
NZ534378A (en) 2002-02-22 2006-10-27 Schering Corp Pharmaceutical formulations of antineoplastic agents, in particular temozolomide, processes of making and using the same
DK1474995T3 (da) * 2003-05-06 2013-02-18 Gumlink As Fremgangsmåde til fremstilling af tyggegummigranulater, et gummisammensætningsekstruder- og granuleringssystem og et tyggegummiprodukt
CN100412084C (zh) * 2003-07-02 2008-08-20 獀洛克斯股份有限公司 热稳定的结晶盐酸表柔比星及其制造方法
US20090099346A1 (en) * 2003-07-02 2009-04-16 Victor Matvienko Thermally stable crystalline epirubicin hydrochloride
WO2005030239A2 (en) * 2003-09-25 2005-04-07 Astellas Pharma Inc. Antitumor agent comprising a histone deacetylase inhibitor and a topoisomerase ii inhibitor
US7388083B2 (en) * 2005-03-07 2008-06-17 Solux Corporation Epimerization of 4′-C bond and modification of 14-CH3-(CO)-fragment in anthracyclin antibiotics
CA2606390A1 (en) * 2005-05-11 2006-11-16 Sicor, Inc. Stable lyophilized anthracycline glycosides
EP1921919B1 (en) 2005-07-14 2012-04-04 Lithera, Inc. Sustained release enhanced lipolytic formulation for regional adipose tissue treatment
CN101331147B (zh) * 2005-12-13 2011-11-30 苏洛克股份有限公司 用于制备4-脱甲基柔红霉素的方法
US8802830B2 (en) * 2005-12-20 2014-08-12 Solux Corporation Synthesis of epirubicin from 13-dihydrodaunorubicine
US8148338B2 (en) * 2006-02-22 2012-04-03 Supratek Pharma Inc. Doxorubicin formulations for anti-cancer use
US7470672B2 (en) * 2006-07-31 2008-12-30 Savvipharm Inc. Compositions and methods of reducing tissue levels of drugs when given as orotate derivatives
CA2687291A1 (en) * 2007-05-16 2008-11-20 Ktb Tumorforschungsgesellschaft Mbh Low-viscous anthracycline formulation
MX2010001263A (es) 2007-09-04 2010-10-04 Meiji Seika Kaisha Inyeccion, solucion de inyeccion y preparacion de equipo de inyeccion.
AU2008315718A1 (en) * 2007-10-26 2009-04-30 Pfizer Products Inc. Idarubicin for the treatment of lymphoma in a dog
US8357785B2 (en) * 2008-01-08 2013-01-22 Solux Corporation Method of aralkylation of 4′-hydroxyl group of anthracylins
US9132084B2 (en) 2009-05-27 2015-09-15 Neothetics, Inc. Methods for administration and formulations for the treatment of regional adipose tissue
GB2477030A (en) * 2010-01-15 2011-07-20 Lithera Inc Lyophilised forms of fluticasone, salmeterol and combinations thereof
WO2012074856A2 (en) 2010-11-24 2012-06-07 Lithera, Inc. Selective, lipophilic, and long-acting beta agonist monotherapeutic formulations and methods for the cosmetic treatment of adiposity and contour bulging
DE102011103751A1 (de) 2011-05-31 2012-12-06 Heraeus Precious Metals Gmbh & Co. Kg Kristallisierung von Epirubicinhydrochlorid
DE102011111991A1 (de) * 2011-08-30 2013-02-28 Lead Discovery Center Gmbh Neue Cyclosporin-Derivate
WO2014093815A1 (en) 2012-12-13 2014-06-19 Cytrx Corporation Anthracycline formulations
CA2912908C (en) 2013-06-05 2021-06-08 Cytrx Corporation Cytotoxic agents comprising covalently protein binding groups for treating brain cancer

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU33730B (en) * 1967-04-18 1978-02-28 Farmaceutici Italia Process for preparing a novel antibiotic substance and salts thereof
US4039663A (en) * 1975-03-19 1977-08-02 Societa' Farmaceutici Italia S.P.A. Daunomycins, process for their uses and intermediates
GB1506200A (en) * 1975-04-30 1978-04-05 Farmaceutici Italia Glycosides
GB1567456A (en) * 1976-11-16 1980-05-14 Farmaceutici Italia Daunomycin derivatives
US4177264A (en) * 1977-10-17 1979-12-04 Sri International N-benzyl anthracyclines
GB2007645B (en) * 1977-10-17 1982-05-12 Stanford Res Inst Int Benzyl anthracyclines and pharmaceutical compositions containing them
JPS563851A (en) * 1979-06-22 1981-01-16 Matsushita Electric Works Ltd Fireplace in floor
JPS5756494A (en) * 1980-09-22 1982-04-05 Microbial Chem Res Found New anthracyclin derivative
US4325947A (en) * 1981-05-12 1982-04-20 Farmitalia Carlo Erba S.P.A. 4-Demethoxy-4'-deoxydoxorubicin
IT1210476B (it) * 1981-05-28 1989-09-14 Erba Farmitalia Antracicline.
US4438105A (en) * 1982-04-19 1984-03-20 Farmaitalia Carlo Erba S.P.A 4'-Iododerivatives of anthracycline glycosides
AU554416B2 (en) * 1982-05-24 1986-08-21 Farmitalia Carlo Erba S.P.A. Anthracycline glycosides
US4464529A (en) * 1982-07-20 1984-08-07 Sri International Analogues of morpholinyl daunorubicin and morpholinyl doxorubicin
CA1248944A (en) * 1982-09-28 1989-01-17 Gareth J. Thomas Anthracycline glycosides
JPS5982395A (ja) * 1982-11-02 1984-05-12 Microbial Chem Res Found アントラサイクリン化合物、その製造法およびその用途
GR79729B (es) * 1982-12-20 1984-10-31 Univ Ohio State Res Found
JPS6092212A (ja) * 1983-10-26 1985-05-23 Kyowa Hakko Kogyo Co Ltd ドキソルビシン塩の製剤
US4537882A (en) * 1984-05-10 1985-08-27 Ohio State University 4-Demethoxy-3'-desamino-2'-halo-anthracycline and pharmaceutical composition containing same

Also Published As

Publication number Publication date
FI86252C (fi) 1992-08-10
HU197988B (en) 1989-07-28
CS756585A2 (en) 1989-11-14
FI853913A0 (fi) 1985-10-08
NO170616B (no) 1992-08-03
NO854194L (no) 1986-04-23
DK481585D0 (da) 1985-10-21
JPS61246129A (ja) 1986-11-01
PT81347B (pt) 1987-11-11
UA34419C2 (uk) 2001-03-15
FI854035A0 (fi) 1985-10-16
DK165620B (da) 1992-12-28
PT81347A (en) 1985-11-01
IE56992B1 (en) 1992-02-26
AT401345B (de) 1996-08-26
PH23982A (en) 1990-02-09
CN85107562B (zh) 1988-06-01
AU572003B2 (en) 1988-04-28
FI853913A (fi) 1986-04-23
FR2571966B1 (fr) 1988-04-15
CH667594A5 (de) 1988-10-31
AU4880585A (en) 1986-05-01
FR2571966A1 (fr) 1986-04-25
HUT40759A (en) 1987-02-27
BG60934B2 (bg) 1996-06-28
SE8504945L (sv) 1986-04-23
DE3536896C2 (de) 1996-11-14
FI854035L (fi) 1986-04-23
NL8502869A (nl) 1986-05-16
YU164485A (en) 1987-10-31
US4675311A (en) 1987-06-23
US5091373A (en) 1992-02-25
NL191308B (nl) 1994-12-16
GB8525709D0 (en) 1985-11-20
BE903484A (fr) 1986-04-21
IE852593L (en) 1986-04-22
GR852549B (es) 1986-02-24
GB2165751B (en) 1988-08-17
IT8522507A0 (it) 1985-10-16
HK94390A (en) 1990-11-23
RU1836088C (ru) 1993-08-23
CS270421B2 (en) 1990-06-13
CN85107562A (zh) 1986-07-23
CA1248453A (en) 1989-01-10
SE8504945D0 (sv) 1985-10-21
GB8426672D0 (en) 1984-11-28
GB2165751A (en) 1986-04-23
FI86252B (fi) 1992-04-30
US5091372A (en) 1992-02-25
DK481585A (da) 1986-04-23
NL191308C (nl) 1995-05-16
KR860003014A (ko) 1986-05-19
ATA303285A (de) 1996-01-15
YU46160B (sh) 1993-05-28
US4840938A (en) 1989-06-20
RU2101018C1 (ru) 1998-01-10
DK165620C (da) 1993-06-01
MY103956A (en) 1993-10-30
KR920005813B1 (ko) 1992-07-20
NO170616C (no) 1992-11-11
DE3536896A1 (de) 1986-04-24
IL76732A0 (en) 1986-02-28
ZA858033B (en) 1986-06-25
NZ213885A (en) 1988-05-30
SG80290G (en) 1990-11-23
IT1186779B (it) 1987-12-16
JPH0611700B2 (ja) 1994-02-16
SE467520B (sv) 1992-08-03
UA19169A (uk) 1997-12-25
IL76732A (en) 1989-07-31
ES8605374A1 (es) 1986-03-16

Similar Documents

Publication Publication Date Title
ES547578A0 (es) Un metodo de produccion de una solucion inyectable de un antraciclina glicosido
ES542028A0 (es) Un metodo de producir una composicion de interleuquina-2
ES545892A0 (es) Un metodo de producir un cigarrillo
ES519533A0 (es) Un metodo de producir una solucion de insulina.
KR860004802A (ko) 염소의 제조방법
FI92052C (fi) Fenolin valmistusmenetelmä
ES544525A0 (es) Un procedimiento para la produccion de una solucion estabi- lizada de una isotiazolona
CS837985A2 (en) Method of isosilybine-free silybine production
DE3583636D1 (de) Herstellungsverfahren von kaliumhydroxyd.
ES550962A0 (es) Un metodo de producir un compuesto de oxirano
IT1223406B (it) Procedimento di produzione di un polifenilenetere
DK179785A (da) Fermenteringsproces
KR870700159A (ko) 서브 프로세스 제어 방법
BR8502568A (pt) Processo de producao de aglomerados nao cozidos
IT1182155B (it) Metodo per la produzione di un elettrodo
ES540907A0 (es) Un metodo de producir una composicion farmaceutica estabili-zada
IT1182583B (it) Cantra protarocchetti per orditoi e metodo per comandare i serrafili di una cantra portarocchetti
DE3586350D1 (de) Synchronisation einer echtzeituhr.
KR860700123A (ko) 항생물질 l17392의 제조 방법
ES549958A0 (es) Un metodo de fabricar una unidad electrolitica
ES528120A0 (es) Un metodo de produccion de una preparacion de plasma activada con zymosan
ES550013A0 (es) Un metodo de produccion de un polipeptido funcional
IT1190249B (it) Metodo di produzione di ferroleghe
KR860004865A (ko) 옥세타논의 제조방법
ES534261A0 (es) Un metodo de produccion de una composicion de aclarrubicina o hidrocloruro de aclarrubicina

Legal Events

Date Code Title Description
PC1A Transfer granted
FD1A Patent lapsed

Effective date: 20051123